StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
6-factor scoring with sector-relative rank. Updated daily.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-12 | $29.37 | $28.68 | -2.35% | 0.5M |
| 05-13 | $28.33 | $28.59 | +0.92% | 0.7M |
| 05-14 | $28.50 | $29.13 | +2.21% | 0.6M |
| 05-15 | $29.44 | $29.66 | +0.75% | 0.5M |
| 05-18 | $37.80 | $37.77 | -0.08% | 13.1M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
RAMP reports on 2026-05-21 after market close. Things to look at before the print:
Educational pre-print checklist — descriptive only, not a directional call.
| Metric | Q2 2026 (Est.) Expected 2026-05-21 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $209.62M | $606.85M | $394.65M | $194.82M | $745.58M |
Operating Income | Not available | $68.17M | $28.65M | $7.22M | $5.40M |
Net Income | Not available | $75.04M | $35.17M | $7.75M | $-814.00K |
EPS (Diluted) | $0.51 | $1.14 | $0.53 | $0.12 | $-0.01 |
Total Assets | Not available | $1.27B | $1.24B | $1.23B | $1.26B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $395.89M | $369.45M | $363.61M | $413.33M |
Free Cash Flow OCF − CapEx | Not available | $107.77M | $40.66M | $-16.16M | $152.92M |
Shares Outstanding | Not available | 65.60M | 66.26M | 66.73M | 66.13M |
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.
Each factor shows RAMP's percentile within the scored universe — observational ranking, not a recommendation.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
What you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
RAMP is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1138-name primary list.
DNA analysis is not available for this ticker.